Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Arcutis

Request full access

Focuses on medical dermatology, leveraging innovations in inflammation and immunology

Thousand Oaks, United StatesFounded 2016Biotech & Life Sciences

About Arcutis

Arcutis Biotherapeutics is a biopharmaceutical company specializing in the development of innovative therapies for dermatological diseases. The company focuses on filling the innovation gap in medical dermatology by leveraging recent advancements in inflammation and immunology. Arcutis serves patients suffering from skin conditions such as psoriasis, eczema, and seborrheic dermatitis. Operating in the biopharmaceutical market, the company employs a business model centered around research and development, clinical trials, and commercialization of its proprietary drug formulations. Revenue is generated through the sale of these specialized therapies once they receive regulatory approval. The leadership team, which includes top dermatologists and a leading topical drug formulator, brings unparalleled expertise to the company's mission of becoming a leader in dermatological innovation.

Source: Dealroom company data

At a glance

Status
Listed
Listing
IPO 2020

Arcutis in the Thousand Oaks ecosystem

Live from Dealroom

The Arcutis office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

5 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A2 investors entered at this stage

Series B and later3 investors entered at this stage

Team profiled 16 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 9 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Patents

Estimated portfolio value
$40M

32 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

See Arcutis on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.